Dendritic cell preparation for immunotherapeutic interventions

Immunotherapy
Thomas SimonMarc Grégoire

Abstract

Much effort has been made over the last decade to use dendritic cells (DCs) in vaccines to induce specific antitumor immune responses. However, the great hope provided by in vitro and in vivo preclinical investigations was not translated to the clinic in terms of clinical efficacy. Thus, one of the challenges resides in optimizing DC-based therapy to give maximum clinical efficacy while using manufacturing processes that enable quality control and scale-up of consistent products. In this article, we review DC biology and the DC-based clinical trials performed to date and focus on the DC maturation status compatible with the goals of cancer immunotherapy. We also highlight the different approaches used in these clinical studies, such as the DC types or subtypes used and their preparation. Finally, we discuss the immunological and clinical outcomes in treated patients, with emphasis on the strategies that could be used to improve DC-based vaccination.

References

Dec 16, 1983·Journal of Immunological Methods·C C CzerkinskyA Tarkowski
Mar 1, 1982·The Journal of Experimental Medicine·J A Keene, J Forman
Jan 1, 1994·Annual Review of Immunology·P Matzinger
Feb 26, 1993·Journal of Immunological Methods·T JungC Rieger
Aug 1, 1996·The Journal of Experimental Medicine·D BoczkowskiE Gilboa
Oct 4, 1996·Science·J D AltmanM M Davis
Feb 1, 1997·Current Opinion in Immunology·M CellaA Lanzavecchia
Jul 7, 1997·The Journal of Experimental Medicine·S R BennettW R Heath
Feb 28, 1998·Immunologic Research·G Trinchieri
Apr 1, 1998·Nature·J Banchereau, R M Steinman
Jul 20, 1999·The Journal of Clinical Investigation·M V DhodapkarN Bhardwaj
Feb 9, 2000·The Journal of Experimental Medicine·R M SteinmanK Inaba
Mar 23, 2000·The Journal of Clinical Investigation·M V DhodapkarN Bhardwaj
Jun 3, 2000·Annual Review of Immunology·L Fong, E G Engleman
Jun 3, 2000·Annual Review of Immunology·J BanchereauK Palucka
Feb 24, 2001·The Journal of Experimental Medicine·M V DhodapkarN Bhardwaj
Mar 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L FongE G Engleman
Jun 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·L FongE G Engleman
Aug 18, 2001·Cell·A Lanzavecchia, F Sallusto
Aug 18, 2001·Cell·J BanchereauG Schuler
Apr 2, 2002·Journal of Immunotherapy·Claire BoccaccioAlessandra Nardin
May 16, 2002·Molecular Immunology·R J CreusotN M Terazzini
Jul 12, 2002·Arthritis Research·Michael L Dustin
Sep 7, 2002·Journal of Immunological Methods·Thomas G BergerBeatrice Schuler-Thurner
Oct 18, 2002·Cancer Immunology, Immunotherapy : CII·Nathalie LabarrièreFrancine Jotereau
Oct 18, 2002·Cancer Immunology, Immunotherapy : CII·Brigitte DrénoFrancine Jotereau

❮ Previous
Next ❯

Citations

Mar 7, 2012·Immunologic Research·Tanja DzopalicMiodrag Colic
Apr 6, 2011·Immunotherapy·John CopierAngus Dalgleish
Jun 9, 2010·Expert Review of Respiratory Medicine·Marc Gregoire
Jun 23, 2011·Expert Review of Vaccines·Byram W Bridle
Mar 5, 2013·Cellular Immunology·Alexander Shimabukuro-VornhagenMichael S von Bergwelt-Baildon
Aug 25, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·João ConstantinoBruno M Neves
Apr 26, 2012·European Journal of Immunology·Chiara NapoletanoMarianna Nuti

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM-CSF

Methods Mentioned

BETA
biopsies

Software Mentioned

Elispot

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.